nach oben

Journal of Neural Transmission

Erschienen in:

28.02.2018 | Neurology and Preclinical Neurological Studies - Review Article

Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities

verfasst von: Barbara Picconi, Elvira De Leonibus, Paolo Calabresi

Erschienen in: Journal of Neural Transmission | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of dopaminergic neurons located in the midbrain. The gold-standard therapy for PD is the restoration of dopamine (DA) levels through the chronic administration of the DA precursor levodopa (L-DOPA). Although levodopa therapy is the main therapeutic approach for PD, its use is limited by the development of very disabling dyskinetic movements, mainly due to the fluctuation of DA cerebral content. Experimental animal models of PD identified in DA D1/ERK-signaling pathway aberrant activation, occurring in striatal projection neurons, coupled with structural spines abnormalities, the molecular and neuronal basis of L-DOPA-induced dyskinesia (LIDs) occurrence. Different electrophysiological approaches allowed the identification of the alteration of homeostatic structural and synaptic changes, the neuronal bases of LIDs either in vivo in parkinsonian patients or in vitro in experimental animals. Here, we report the most recent studies showing electrophysiological and morphological evidence of aberrant synaptic plasticity in parkinsonian patients during LIDs in different basal ganglia nuclei and also in cortical transmission, accounting for the complexity of the synaptic changes during dyskinesias. All together, these studies suggest that LIDs are associated with a loss of homeostatic synaptic mechanisms.

Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12(10):366–375CrossRefPubMed

Augustin SM, Beeler JA, McGehee DS, Zhuang X (2014) Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons. J Neurosci 34(19):6692–6699. https://doi.org/10.1523/JNEUROSCI.3906-13.2014 CrossRefPubMedPubMedCentral

Ayala A, Trivino-Juarez JM, Forjaz MJ, Rodriguez-Blazquez C, Rojo-Abuin JM, Martinez-Martin P (2017) Parkinson’s disease severity at 3 years can be predicted from non-motor symptoms at baseline. Front Neurol 8:551. https://doi.org/10.3389/fneur.2017.00551 CrossRefPubMedPubMedCentral

Barker RA, Williams-Gray CH (2016) Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol Appl Neurobiol 42(1):6–19. https://doi.org/10.1111/nan.12303 CrossRefPubMed

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdere P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bezard E (2015) Pathophysiology of l-DOPA-induced motor and non-motor complications in Parkinson’s disease. Prog Neurobiol 132:96–168. https://doi.org/10.1016/j.pneurobio.2015.07.002 CrossRefPubMed

Belujon P, Lodge DJ, Grace AA (2010) Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. Mov Disord 25(11):1568–1576. https://doi.org/10.1002/mds.23245 CrossRefPubMedPubMedCentral

Bido S, Solari N, Indrigo M, D’Antoni A, Brambilla R, Morari M, Fasano S (2015) Differential involvement of Ras-GRF1 and Ras-GRF2 in l-DOPA-induced dyskinesia. Ann Clin Transl Neurol 2(6):662–678. https://doi.org/10.1002/acn3.202 CrossRefPubMedPubMedCentral

Bliss TV, Gardner-Medwin AR (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path. J Physiol 232(2):357–374CrossRefPubMedPubMedCentral

Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232(2):331–356CrossRefPubMedPubMedCentral

Calabresi P, Ghiglieri V, Mazzocchetti P, Corbelli I, Picconi B (2015) Levodopa-induced plasticity: a double-edged sword in Parkinson’s disease? Philos Trans R Soc Lond B Biol Sci 370(1672):20140184CrossRefPubMedPubMedCentral

Calabresi P, Maj R, Mercuri NB, Bernardi G (1992a) Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett 142(1):95–99CrossRefPubMed

Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992b) Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J Neurosci 12(11):4224–4233CrossRefPubMed

Calabresi P, Pisani A, Mercuri NB, Bernardi G (1992c) Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur J Neurosci 4(10):929–935CrossRefPubMed

Calabresi P, Pisani A, Rothwell J, Ghiglieri V, Obeso JA, Picconi B (2016) Hyperkinetic disorders and loss of synaptic downscaling. Nat Neurosci 19(7):868–875. https://doi.org/10.1038/nn.4306 CrossRefPubMed

Centonze D, Costa C, Rossi S, Prosperetti C, Pisani A, Usiello A, Bernardi G, Mercuri NB, Calabresi P (2006) Chronic cocaine prevents depotentiation at corticostriatal synapses. Biol Psychiatry 60(5):436–443CrossRefPubMed

Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, Bernardi G (1999) Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol 82(6):3575–3579CrossRefPubMed

Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C (2005) Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience 133(3):831–840CrossRefPubMed

Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES, Grandy DK, Low MJ, Rubinstein M, Ariano MA, Levine MS (2001) Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85(2):659–670CrossRefPubMed

Cerovic M, Bagetta V, Pendolino V, Ghiglieri V, Fasano S, Morella I, Hardingham N, Heuer A, Papale A, Marchisella F, Giampa C, Calabresi P, Picconi B, Brambilla R (2015) Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in l-DOPA-induced dyskinesia. Biol Psychiatry 77(2):106–115. https://doi.org/10.1016/j.biopsych.2014.04.002 CrossRefPubMed

Cools R, Gibbs SE, Miyakawa A, Jagust W, D’Esposito M (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28(5):1208–1212. https://doi.org/10.1523/JNEUROSCI.4475-07.2008 CrossRefPubMed

Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9(2):251–259. https://doi.org/10.1038/nn1632 CrossRefPubMed

De Leonibus E, Pascucci T, Lopez S, Oliverio A, Amalric M, Mele A (2007) Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology 194(4):517–525. https://doi.org/10.1007/s00213-007-0862-4 CrossRefPubMed

Deutch AY, Colbran RJ, Winder DJ (2007) Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat Disord 13(Suppl 3):S251–258. https://doi.org/10.1016/S1353-8020(08)70012-9 CrossRefPubMedPubMedCentral

Fasano S, Bezard E, D’Antoni A, Francardo V, Indrigo M, Qin L, Dovero S, Cerovic M, Cenci MA, Brambilla R (2010) Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with l-DOPA-induced dyskinesia. Proc Natl Acad Sci USA 107(50):21824–21829. https://doi.org/10.1073/pnas.1012071107 CrossRefPubMed

Fino E, Paille V, Cui Y, Morera-Herreras T, Deniau JM, Venance L (2010) Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. J Physiol 588(Pt 16):3045–3062. https://doi.org/10.1113/jphysiol.2010.188466 CrossRefPubMedPubMedCentral

Funamizu Y, Nishijima H, Ueno T, Ueno S, Mizukami H, Yagihashi S, Tomiyama M (2017) Morphological dendritic spine changes of medium spiny neurons in the nucleus accumbens in 6-hydroxydopamine-lesioned rats treated with levodopa. Neurosci Res 121:49–53. https://doi.org/10.1016/j.neures.2017.03.010 CrossRefPubMed

Gagnon D, Petryszyn S, Sanchez MG, Bories C, Beaulieu JM, De Koninck Y, Parent A, Parent M (2017) Striatal neurons expressing D1 and D2 receptors are morphologically distinct and differently affected by dopamine denervation in mice. Sci Rep 7:41432. https://doi.org/10.1038/srep41432 CrossRefPubMedPubMedCentral

Giordano N, Iemolo A, Mancini M, Cacace F, De Risi M, Claudio Latagliata EC, Ghiglieri V, Bellenchi GC, Puglisi-Allegra S, Calabresi P, Picconi B, De Leonibus E (2018) Motor learning and metaplasticity in striatal neurons: relevance for Parkinson’s disease. Brain 141(2):505–520. https://doi.org/10.1093/brain/awx351 CrossRefPubMed

Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agro A, Maccarrone M (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 22(16):6900–6907CrossRefPubMed

Hebb DO (1949) The organization of behavior. Wiley, New York

Huang YZ, Rothwell JC, Lu CS, Chuang WL, Chen RS (2011) Abnormal bidirectional plasticity-like effects in Parkinson’s disease. Brain 134(Pt 8):2312–2320. https://doi.org/10.1093/brain/awr158 CrossRefPubMed

Ingham CA, Hood SH, Taggart P, Arbuthnott GW (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18(12):4732–4743CrossRefPubMed

Ingham CA, Hood SH, van Maldegem B, Weenink A, Arbuthnott GW (1993) Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp Brain Res 93(1):17–27CrossRefPubMed

Kawashima S, Ueki Y, Mima T, Fukuyama H, Ojika K, Matsukawa N (2013) Differences in dopaminergic modulation to motor cortical plasticity between Parkinson’s disease and multiple system atrophy. PLoS One 8(5):e62515. https://doi.org/10.1371/journal.pone.0062515 CrossRefPubMedPubMedCentral

Lovinger DM, Tyler EC, Merritt A (1993) Short- and long-term synaptic depression in rat neostriatum. J Neurophysiol 70(5):1937–1949CrossRefPubMed

Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agro A, Calabresi P (2003) Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J Neurochem 85(4):1018–1025CrossRefPubMed

Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44(1):5–21. https://doi.org/10.1016/j.neuron.2004.09.012 CrossRefPubMed

Martella G, Tassone A, Sciamanna G, Platania P, Cuomo D, Viscomi MT, Bonsi P, Cacci E, Biagioni S, Usiello A, Bernardi G, Sharma N, Standaert DG, Pisani A (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132(Pt 9):2336–2349. https://doi.org/10.1093/brain/awp194 CrossRefPubMedPubMedCentral

Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H (2004) Structural basis of long-term potentiation in single dendritic spines. Nature 429(6993):761–766. https://doi.org/10.1038/nature02617 CrossRefPubMedPubMedCentral

McNeill TH, Brown SA, Rafols JA, Shoulson I (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson’s disease. Brain Res 455(1):148–152CrossRefPubMed

Mercuri NB, Bernardi G (2005) The ‘magic’ of l-DOPA: why is it the gold standard Parkinson’s disease therapy? Trends Pharmacol Sci 26(7):341–344. https://doi.org/10.1016/j.tips.2005.05.002 CrossRefPubMed

Molina-Luna K, Pekanovic A, Rohrich S, Hertler B, Schubring-Giese M, Rioult-Pedotti MS, Luft AR (2009) Dopamine in motor cortex is necessary for skill learning and synaptic plasticity. PLoS One 4(9):e7082. https://doi.org/10.1371/journal.pone.0007082 CrossRefPubMedPubMedCentral

Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R (2006) Motor cortex plasticity in Parkinson’s disease and levodopa-induced dyskinesias. Brain 129(Pt 4):1059–1069. https://doi.org/10.1093/brain/awl031 CrossRefPubMed

Nishijima H, Arai A, Kimura T, Mori F, Yamada J, Migita K, Wakabayashi K, Baba M, Ueno S, Tomiyama M (2013) Drebrin immunoreactivity in the striatum of a rat model of levodopa-induced dyskinesia. Neuropathology 33(4):391–396. https://doi.org/10.1111/neup.12009 CrossRefPubMed

Nishijima H, Ueno T, Ueno S, Mori F, Miki Y, Tomiyama M (2017) Levodopa-induced morphologic changes of prefrontal pyramidal tract-type neurons in a rat model of Parkinson’s disease. Neurosci Res 115:54–58. https://doi.org/10.1016/j.neures.2016.10.001 CrossRefPubMed

Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F (2004) Levodopa in the treatment of Parkinson’s disease: current controversies. Mov Disord 19(9):997–1005. https://doi.org/10.1002/mds.20243 CrossRefPubMed

Olanow CW, Schapira AH (2013) Therapeutic prospects for Parkinson disease. Ann Neurol 74(3):337–347. https://doi.org/10.1002/ana.24011 CrossRefPubMed

Parnetti L, Farotti L, Eusebi P, Chiasserini D, De Carlo C, Giannandrea D, Salvadori N, Lisetti V, Tambasco N, Rossi A, Majbour NK, El-Agnaf O, Calabresi P (2014) Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson’s Disease. Front Aging Neurosci 6:53. https://doi.org/10.3389/fnagi.2014.00053 CrossRefPubMedPubMedCentral

Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P (2003) Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat Neurosci 6(5):501–506CrossRefPubMed

Picconi B, Paille V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P (2008) l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol Dis 29(2):327–335CrossRefPubMed

Poewe W (2005) Treatment of dementia with Lewy bodies and Parkinson’s disease dementia. Mov Disord 20(Suppl 12):S77–82. https://doi.org/10.1002/mds.20544 CrossRefPubMed

Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD (2009) Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson’s disease patients. Brain 132(Pt 2):309–318. https://doi.org/10.1093/brain/awn322 CrossRefPubMed

Prescott IA, Liu LD, Dostrovsky JO, Hodaie M, Lozano AM, Hutchison WD (2014) Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Neurobiol Dis 71:24–33. https://doi.org/10.1016/j.nbd.2014.08.002 CrossRefPubMed

Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, Hall RA, Smith Y (2008) Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 27(7):1647–1658. https://doi.org/10.1111/j.1460-9568.2008.06136.x CrossRefPubMed

Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y (2006) Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 499(2):231–243. https://doi.org/10.1002/cne.21099 CrossRefPubMedPubMedCentral

Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E (2009) Antagonizing L-type Ca2 + channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry 65(6):518–526. https://doi.org/10.1016/j.biopsych.2008.09.008 CrossRefPubMed

Segal M (2010) Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability. Eur J Neurosci 31(12):2178–2184. https://doi.org/10.1111/j.1460-9568.2010.07270.x CrossRefPubMed

Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol 342(3):321–334. https://doi.org/10.1002/cne.903420302 CrossRefPubMed

Shen W, Flajolet M, Greengard P, Surmeier DJ (2008) Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321(5890):848–851. https://doi.org/10.1126/science.1160575 CrossRefPubMedPubMedCentral

Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ (2015) M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of l-DOPA-induced dyskinesia. Neuron 88(4):762–773. https://doi.org/10.1016/j.neuron.2015.10.039 CrossRefPubMedPubMedCentral

Shen W, Tian X, Day M, Ulrich S, Tkatch T, Nathanson NM, Surmeier DJ (2007) Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci 10(11):1458–1466. https://doi.org/10.1038/nn1972 CrossRefPubMed

Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839–840. https://doi.org/10.1038/42166 CrossRefPubMed

Stefan K, Kunesch E, Cohen LG, Benecke R, Classen J (2000) Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 123(Pt 3):572–584CrossRefPubMed

Stefan K, Wycislo M, Classen J (2004) Modulation of associative human motor cortical plasticity by attention. J Neurophysiol 92(1):66–72. https://doi.org/10.1152/jn.00383.2003 CrossRefPubMed

Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R (2016) l-DOPA oppositely regulates synaptic strength and spine morphology in D1 and D2 striatal projection neurons in dyskinesia. Cereb Cortex 26(11):4253–4264. https://doi.org/10.1093/cercor/bhw263 CrossRefPubMedPubMedCentral

Suarez LM, Solis O, Carames JM, Taravini IR, Solis JM, Murer MG, Moratalla R (2014) l-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatry 75(9):711–722. https://doi.org/10.1016/j.biopsych.2013.05.006 CrossRefPubMed

Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30(5):228–235. https://doi.org/10.1016/j.tins.2007.03.008 CrossRefPubMed

Tang K, Low MJ, Grandy DK, Lovinger DM (2001) Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 98(3):1255–1260. https://doi.org/10.1073/pnas.031374698 CrossRefPubMed

Thiele SL, Chen B, Lo C, Gertler TS, Warre R, Surmeier JD, Brotchie JM, Nash JE (2014) Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiol Dis 71:334–344. https://doi.org/10.1016/j.nbd.2014.08.006 CrossRefPubMedPubMedCentral

Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, Vuckovic MG, Jakowec MW (2014) Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease. Neurobiol Dis 63:201–209. https://doi.org/10.1016/j.nbd.2013.11.017 CrossRefPubMed

Tozzi A, de Iure A, Di Filippo M, Tantucci M, Costa C, Borsini F, Ghiglieri V, Giampa C, Fusco FR, Picconi B, Calabresi P (2011) The distinct role of medium spiny neurons and cholinergic interneurons in the D(2)/A(2)A receptor interaction in the striatum: implications for Parkinson’s disease. J Neurosci 31(5):1850–1862. https://doi.org/10.1523/JNEUROSCI.4082-10.2011 CrossRefPubMed

Ueki Y, Mima T, Kotb MA, Sawada H, Saiki H, Ikeda A, Begum T, Reza F, Nagamine T, Fukuyama H (2006) Altered plasticity of the human motor cortex in Parkinson’s disease. Ann Neurol 59(1):60–71. https://doi.org/10.1002/ana.20692 CrossRefPubMed

Ueno T, Nishijima H, Ueno S, Tomiyama M (2017) Spine Enlargement of pyramidal tract-type neurons in the motor cortex of a rat model of levodopa-induced dyskinesia. Front Neurosci 11:206. https://doi.org/10.3389/fnins.2017.00206 CrossRefPubMedPubMedCentral

Villalba RM, Lee H, Smith Y (2009) Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 215(2):220–227. https://doi.org/10.1016/j.expneurol.2008.09.025 CrossRefPubMed

Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E (2009) Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8(12):1140–1149. https://doi.org/10.1016/S1474-4422(09)70287-X CrossRefPubMed

Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. Lancet Neurol 16(3):238–250. https://doi.org/10.1016/S1474-4422(17)30004-2 CrossRefPubMed

Wang Q, Zhang W (2016) Maladaptive synaptic plasticity in l-DOPA-induced dyskinesia. Front Neural Circuits 10:105. https://doi.org/10.3389/fncir.2016.00105 PubMedPubMedCentralCrossRef

Wolters A, Sandbrink F, Schlottmann A, Kunesch E, Stefan K, Cohen LG, Benecke R, Classen J (2003) A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol 89(5):2339–2345. https://doi.org/10.1152/jn.00900.2002 CrossRefPubMed

Yasumatsu N, Matsuzaki M, Miyazaki T, Noguchi J, Kasai H (2008) Principles of long-term dynamics of dendritic spines. J Neurosci 28(50):13592–13608. https://doi.org/10.1523/JNEUROSCI.0603-08.2008 CrossRefPubMedPubMedCentral

Yin HH, Mulcare SP, Hilario MR, Clouse E, Holloway T, Davis MI, Hansson AC, Lovinger DM, Costa RM (2009) Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 12(3):333–341. https://doi.org/10.1038/nn.2261 CrossRefPubMedPubMedCentral

Zhang Y, Meredith GE, Mendoza-Elias N, Rademacher DJ, Tseng KY, Steece-Collier K (2013) Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J Neurosci 33(28):11655–11667. https://doi.org/10.1523/JNEUROSCI.0288-13.2013 CrossRefPubMedPubMedCentral

Titel: Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities
verfasst von: Barbara Picconi
Elvira De Leonibus
Paolo Calabresi
Publikationsdatum: 28.02.2018
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 8/2018
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-018-1864-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

Impulse control disorders in Parkinson’s disease

The striatal cholinergic system in l-dopa-induced dyskinesias

The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies